Search research articles
Contact Us
Filters
Showing results (1-10 of 360) with videos related to
Page
of 36
Sort By:
Expert Opinion on Pharmacotherapy
|
September 22, 2012
Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus
Masahiro Inoue
Materials (Basel, Switzerland)
|
January 25, 2025
Control of Silver Micro-Flakes Sintering and Connection Properties of Epoxy-Based Conductive Adhesives by the Effectiveness of Binder Chemistry
Takanori Fukushima, Masahiro Inoue
Cells
|
September 26, 2025
Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance
Roberto Coppo, Masahiro Inoue
Organic Letters
|
August 28, 2004
Studies on catalytic asymmetric Nozaki-Hiyama propargylation
Masahiro Inoue, Masahisa Nakada
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 15, 2011
[Hypoxic microenvironment and cancer dormancy]
Hiroaki Okuyama, Masahiro Inoue
Cells
|
May 22, 2019
Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
Jumpei Kondo, Masahiro Inoue
Cancer Science
|
December 22, 2018
Dormancy in cancer
Hiroko Endo, Masahiro Inoue
Cancer Science
|
September 1, 2022
Abnormality of apico-basal polarity in adenocarcinoma
Kunishige Onuma, Masahiro Inoue
Oncology Letters
|
February 20, 2016
Circulating tumor cell count as a biomarker of a specific gastric cancer subgroup characterized by bone metastasis and/or disseminated intravascular coagulation - an early indicator of chemotherapeutic response
Masahiro Inoue, Kazunori Otsuka, Hiroyuki Shibata
Journal of the American Chemical Society
|
January 30, 2003
Asymmetric catalysis of Nozaki-Hiyama allylation and methallylation with a new tridentate bis(oxazolinyl)carbazole ligand
Masahiro Inoue, Takahiro Suzuki, Masahisa Nakada
Page
of 36
Search research articles
Search
Showing results (1-10 of 360) with videos related to
Sort By:
Page
of 36
Expert Opinion on Pharmacotherapy
|
September 22, 2012
Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus
Masahiro Inoue
Materials (Basel, Switzerland)
|
January 25, 2025
Control of Silver Micro-Flakes Sintering and Connection Properties of Epoxy-Based Conductive Adhesives by the Effectiveness of Binder Chemistry
Takanori Fukushima, Masahiro Inoue
Cells
|
September 26, 2025
Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance
Roberto Coppo, Masahiro Inoue
Organic Letters
|
August 28, 2004
Studies on catalytic asymmetric Nozaki-Hiyama propargylation
Masahiro Inoue, Masahisa Nakada
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 15, 2011
[Hypoxic microenvironment and cancer dormancy]
Hiroaki Okuyama, Masahiro Inoue
Cells
|
May 22, 2019
Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
Jumpei Kondo, Masahiro Inoue
Cancer Science
|
December 22, 2018
Dormancy in cancer
Hiroko Endo, Masahiro Inoue
Cancer Science
|
September 1, 2022
Abnormality of apico-basal polarity in adenocarcinoma
Kunishige Onuma, Masahiro Inoue
Oncology Letters
|
February 20, 2016
Circulating tumor cell count as a biomarker of a specific gastric cancer subgroup characterized by bone metastasis and/or disseminated intravascular coagulation - an early indicator of chemotherapeutic response
Masahiro Inoue, Kazunori Otsuka, Hiroyuki Shibata
Journal of the American Chemical Society
|
January 30, 2003
Asymmetric catalysis of Nozaki-Hiyama allylation and methallylation with a new tridentate bis(oxazolinyl)carbazole ligand
Masahiro Inoue, Takahiro Suzuki, Masahisa Nakada
Page
of 36